Abbott secures win with Unified Patent Court ordering complete revocation of Dexcom glucose monitor patent
The Unified Patent Court ruled in favor of defendant Abbott Laboratories in an infringement action initiated by Dexcom Inc. The parties are competitors in the market for continuous glucose monitors, or...To view the full article, register now.
Already a subscriber? Click here to view full article